PSA level greater than or equal to two

Clinical trials for PSA level greater than or equal to two explained in plain language.

Never miss a new study

Get alerted when new PSA level greater than or equal to two trials appear

Sign up with your email to follow new studies for PSA level greater than or equal to two, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Can a Chemo-Targeted drug combo outsmart Treatment-Resistant prostate cancer?

Disease control Stopped early

This phase 2 trial is testing whether giving two chemotherapy drugs (docetaxel and carboplatin) followed by a maintenance drug called rucaparib can help men with metastatic castration-resistant prostate cancer that has specific DNA repair defects. The idea is that the chemo shrin…

Matched conditions: PSA LEVEL GREATER THAN OR EQUAL TO TWO

Phase 2 • Sponsor: University of Washington • Aim: Disease control

Last updated Aug 28, 2026 00:00 UTC

PSA level greater than or equal to two

Get alerted when new PSA level greater than or equal to two trials appear

Can a Chemo-Targeted drug combo outsmart Treatment-Resistant prostate cancer?